gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
Published 2 years ago • 1.3K plays • Length 3:42Download video MP4
Download video MP3
Similar videos
-
3:50
gynecologic oncology at asco 2022: tv pembro in first-line recurrent or metastatic cervical cancer
-
0:46
gynecologic oncology at asco 2022: subgroup analysis of keynote-826
-
1:11
gyn onc at asco 2022: randomized phase iii trial on trabectedin in recurrent ovarian cancer
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
2:44
gynecologic oncology at asco 2022: session highlights to share with your patients
-
0:36
athena trial: post adjuvant chemo in ovarian cancer | premal thaker, md, ms | asco22 gyn updates
-
2:34
gynecologic oncology research at asco 2017: icon6 ovarian cancer trial
-
7:57
gynecologic oncology highlights at asco20 #sgoatasco
-
1:11
gynecologic oncology at asco 2018: ovarian cancer, mito16b-mango ov2b-engot ov17, pignata
-
9:22
rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
-
3:11
gynecologic cancer studies: what to look for at asco 2022
-
0:53
gynecologic oncology at asco 2018: ovarian cancer, jcog0602, onda
-
28:52
gynecologic cancer education: clinical trials update
-
43:26
gynecologic oncology: what you need to know in 2022?
-
2:09
gynecologic oncology research at asco 2017: ovarian cancer surgery trials
-
19:15
understanding gynecologic cancer clinical trials
-
15:12
understanding ovarian cancer
-
3:47
gog-0218: which patients with ovarian cancer experience highest benefit from 1l bevacizumab?